Alterations in this phosphatase activity have been reported in AD-affected brain regions and has been linked to tau hyperphosphorylation, amyloidogenesis and synaptic deficits (Sontag and Sontag, 2014). This evidence concerns the gene MAPT and Alzheimer disease.